|
1
|
Yimam M, Lee YC, Wright L, Jiao P, Horm T,
Hong M, Brownell L and Jia Q: A botanical composition mitigates
cartilage degradations and pain sensitivity in osteoarthritis
disease model. J Med Food. 20:568–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ickinger C and Tikly M: Current approach
to diagnosis and management of osteoarthritis. SA Fam Pract.
52:382–390. 2010.
|
|
3
|
Karsdal MA, Sondergaard BC, Arnold M and
Christiansen C: Calcitonin affects both bone and cartilage: A dual
action treatment for osteoarthritis? Ann N Y Acad Sci.
1117:181–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang LB, Man ZT, Li W, Zhang W, Wang XQ
and Sun S: Calcitonin protects chondrocytes from
lipopolysaccharide-induced apoptosis and inflammatory response
through MAPK/Wnt/NF-κB pathways. Mol Immunol. 87:249–257. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan XL, Wei LJ, Wang WY and Zhang L:
Effect of calcitonin on the inflammatory reaction in IL-1β-induced
chondrocytes in rats. Jie Fang Jun Yi Xue Za Zhi. 24:47–51.
2015.(In Chinese).
|
|
6
|
Zhou Y, Wang T, Hamilton JL and Chen D:
Wnt/β-catenin signaling in osteoarthritis and in other forms of
arthritis. Curr Rheumatol Rep. 19:532017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rossini M, Gatti D and Adami S:
Involvement of WNT/β-catenin signaling in the treatment of
osteoporosis. Calcif Tissue Int. 93:121–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu HY and Zheng Y: A study on
Wnt/β-catenin signal pathway in rabbit models with osteoarthritis.
Feng Shi Bing Yu Guan Jie Yan. 4:5–8. 2015.(In Chinese).
|
|
9
|
Zhang YN, Wang WY, Zhang L, Hu HY, Li B
and Wang ZY: Effect of calcitonin on beta-catenin and secreted
frizzled-related protein 1 in articular cartilages. Zhong Guo Zu
Zhi Gong Cheng Yan Jiu Lin Chuang Kang Fu. 14:7601–7604. 2010.(In
Chinese).
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alcaraz MJ, Megías J, García-Arnandis I,
Clérigues V and Guillén MI: New molecular targets for the treatment
of osteoarthritis. Biochem Pharmacol. 80:13–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jacques C, Recklies AD, Levy A and
Berenbaum F: HC-gp39 contributes to chondrocyte differentiation by
inducing SOX9 and type II collagen expressions. Osteoarthritis
Cartilage. 15:138–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zou J, Li XL, Shi ZM and Xue JF: Effects
of C-myc gene silencing on interleukin-1β-induced rat chondrocyte
cell proliferation, apoptosis and cytokine expression. J Bone Miner
Metab. 36:286–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
You X: The experimental research of the
effects of calcitonin on cytokines and apoptosis of articular
chondrocytes during the development of knee osteoarthritis in
rabbits. Chin J Osteoporosis. 18:223–228. 2012.(In Chinese).
|
|
16
|
Greco KV, Nalesso G, Kaneva MK, Sherwood
J, Iqbal AJ, Moradi-Bidhendi N, Dell'Accio F and Perretti M:
Analyses on the mechanisms that underlie the chondroprotective
properties of calcitonin. Biochem Pharmacol. 91:348–358. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sumer EU, Qvist P and Tankó LB: Matrix
metalloproteinase and aggrecanase generated aggrecan fragments:
Implications for the diagnostics and therapeutics of destructive
joint diseases. Drug Dev Res. 68:1–13. 2007. View Article : Google Scholar
|
|
18
|
Cheng T, Zhang L, Fu X, Wang W, Xu H, Song
H and Zhang Y: The potential protective effects of calcitonin
involved in coordinating chondrocyte response, extracellular
matrix, and subchondral trabecular bone in experimental
osteoarthritis. Connect Tissue Res. 54:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Xie ZG, Xie Y and Dong QR:
Calcitonin treatment is associated with less severe osteoarthritis
and reduced toll-like receptor levels in a rat model. J Orthop Sci.
19:1019–1027. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Enochson L, Stenberg J, Brittberg M and
Lindahl A: GDF5 reduces MMP13 expression in human chondrocytes via
DKK1 mediated canonical Wnt signaling inhibition. Osteoarthritis
Cartilage. 22:566–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang YN: Effect of calcitonin on
articular cartilage chondrocytes of osteoarthritis. Journal.
2009.
|
